Biotech
EDMONTON, ALBERTA: EDMONTON, ALBERTA -- (Marketwired) -- 09/27/16 -- (TSX VENTURE: CZO) ("Ceapro" or the "Company"), a growth-stage biotechnology company focused on the development and commercializ ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 09/26/16 -- RepliCel Life Sciences Inc. (OTCQB: REPCD)(TSX VENTURE: RP)(FRANKFURT: P6P2) ("RepliCel" or the "Company"), a clinical ...
CAMBRIDGE, MASSACHUSETTS: CAMBRIDGE, MASSACHUSETTS -- (Marketwired) -- 09/26/16 -- VBI Vaccines Inc. (NASDAQ: VBIV)(TSX: VBV) ("VBI") today announced the voting results from its annual general and special meeting ( ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 09/26/16 -- Pacific Therapeutics Ltd. (CSE: PT)(OTC PINK: PCFTF)(Frankfurt: 1P3) (the "Company") announces that it has received a corporate ...
CAMBRIDGE, MASSACHUSETTS: CAMBRIDGE, MASSACHUSETTS -- (Marketwired) -- 09/26/16 -- VBI Vaccines Inc. (NASDAQ: VBIV)(TSX: VBV) ("VBI") is scheduled to present at the on Tuesday, September 27, 2016 at 10:00 AM ET. Th ...
LEXINGTON, MA: LEXINGTON, MA -- (Marketwired) -- 09/26/16 -- Aldeyra Therapeutics, Inc. (NASDAQ: ALDX)First-Ever Vehicle-Controlled Phase III Clinical Trial in Noninfectious Anterior UveitisFirst-Ever Phase III Cli ...
HALIFAX, NOVA SCOTIA: Presentations at RSV16, World Vaccine Congress Europe and IDWeek Conferences Highlight Company's Progress in Using DepoVax(TM)-based Agents to Address Respiratory Syncytial Virus (RSV) and Life-T ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 09/22/16 -- Hemostemix Inc. ("Hemostemix" or the "Company") (TSX VENTURE: HEM) (OTCQB: HMTXF) today announces a non-brokered private placemen ...
RALEIGH-DURHAM, NC: Prestigious Conference Presented by the Center for Dermal Research at Rutgers University ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 09/21/16 -- Hemostemix Inc. ("Hemostemix" or the "Company) (TSX VENTURE: HEM)(OTCQX: HMTXF), a clinical-stage autologous cell-therapy company, ann ...
EDMONTON, ALBERTA: Ceapro Enters into a multi-partners' project through Alberta-Germany Collaboration Fund for Product Development and Commercialization of PGX Technology ...
CAMBRIDGE, MASSACHUSETTS: CAMBRIDGE, MASSACHUSETTS -- (Marketwired) -- 09/20/16 -- VBI Vaccines Inc. (NASDAQ: VBIV)(TSX: VBV) ("VBI") today announced that it has completed enrollment and initial dosing of all partic ...
HALIFAX, NOVA SCOTIA: HALIFAX, NOVA SCOTIA -- (Marketwired) -- 09/20/16 -- Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX: IMV)(OTCQX: IMMVF), a clinical-stage vaccine and immunotherapy com ...
LYON, FRANCE: LYON, FRANCE -- (Marketwired) -- 09/19/16 -- Flamel Technologies (NASDAQ: FLML) today announced that management will present at the Ladenburg Thalmann 2016 Healthcare Conference. Michael Anderson, Ch ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 09/19/16 -- Aphria Inc. ("Aphria") (TSX VENTURE: APH)(OTCQB: APHQF), in connection with its previously announced licensing deal with Tokyo Smoke, a pre ...
SYDNEY, AUSTRALIA: New Molecular Assay Is Only Commercial Test to Detect Both M. genitalium and Antibiotic Resistance for One of the World's Fastest Spreading Sexually Transmitted Diseases ...
LYON, FRANCE: LYON, FRANCE -- (Marketwired) -- 09/19/16 -- Flamel Technologies (NASDAQ: FLML) today announced it will host a meeting for investors and analysts on Monday, September 26, 2016. The event will take pl ...
LOS ALTOS, CA: First-in-Human Trial Achieves Safety, Tolerability, and PK Goals, With Early Signals of Efficacy ...
SANTA ANA, CA: SANTA ANA, CA -- (Marketwired) -- 09/16/16 -- Io Therapeutics, Inc., today, reported data demonstrating that the company's experimental rexinoid nuclear receptor (RXR) agonist compound, IRX4204, ...
